Background: The goal of this prospective study was to determine the frequency of micrometastases in patients with squamous cell carcinoma (SCC) of the oral cavity, pharynx and larynx in whom elective neck dissection was indicated (cN0). Patients and Methods: A total of 12 patients (10 males and 2 females) were enrolled in the study. The age ranged 42-73 years (median 62 years). Elective neck dissection was performed in all patients (8 ipsilateral, 4 bilateral) and a total of 256 lymph nodes were removed and sent for microscopic examination. Results: The presence of tumor cells in cervical lymph nodes was found in 5/12 (42%) patients. Micrometastases of SCC were found in two patients and isolated tumor cells (ITC) in two other patients. In the remaining one patient with oropharyngeal SCC, a micrometastasis of papillary thyroid carcinoma (PTC) was detected. Positive lymph nodes were localized in level II in three patients with SCC of larynx, hypopharynx and tongue base, respectively, in level I in one patient with SCC of oral tongue and in level III in one patient with PTC. Conclusion: Our results indicate that SCC of head and neck has a high potential for creating micrometastases which frequency is higher compared to clinically detected macrometastases. Therefore, elective neck dissection or radiotherapy of the neck should be considered in patients with high risk of occult metastases or micrometastases.
Introduction
The presence of cervical lymph node metastases is nowadays one of the most important prognostic factors of head and neck squamous cell carcinoma (HNSCC), particularly in HPV-negative tumors. It is recommended to differentiate macrometastases from occult metastases, micrometastases and isolated tumor cells (ITC). Even if the prognosis of disease in presence of ITC is still unclear, presence of micrometastases has been proven to be clinically significant. Because it is difficult to detect micrometastases and ITC by common diagnostic methods or by standard histopathological examinations, immunohistochemical and molecular methods are often used for their detection.
The aim of our study was to determine the frequency of micrometastases and ITC in HNSSC patients, who were indicated for elective neck dissection.
Materials and methods
Prospective study with approval of regional ethical committee was performed. All patients with squamous cell carcinoma (SCC) of the oral cavity, pharynx and larynx, indicated for elective neck dissection (cN0) in time period from 1 January 2012 to 31 December 2013, were enrolled in the study. Our study group represents a total number of 12 patients (10 males and 2 females) treated in the Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital in Hradec Králové. The age ranged 42-73 years (median 62 years). All cases of laryngeal tumors were T4 stages, whereas in cases of pharyngeal tumors the size ranged between T1-T4 stages (Table 1) . Elective neck dissection (cN0) was performed in all patients and a total of 256 lymph nodes were removed and sent for microscopic examination. The extent of neck dissection was modified by the size and location of primary tumor (8× ipsilateral, 4× bilateral, in most cases levels I-IV, or II-V).
The pathologic evaluation and reporting of lymph nodes generally followed the 2005 ASCO (American Society of Clinical Oncology) Guideline (1), with attention to the recently proposed protocol recommendations (2) .
The fibro-fatty tissue was carefully dissected to identify all lymph nodes. The number and the size of the largest lymph node were recorded. All lymph nodes were cut into sections not thicker than 2 mm through and parallel to the longest axis. All sections were embedded and submitted for T1  27  negative  -8  male  59  tonsil  T2  24  negative  -9  male  61  tonsil  T1  2  negative  -10  male  42  body of tongue  T2  14  negative  -11  male  62  hypopharynx  T2  19  micrometastasis (SCC)  II, contralateral  12  female  68  larynx  T4a  16  micrometastasis (SCC) II, ipsilateral Abbreviations: ITC = isolated tumor cells, SCC = squamous cell carcinoma, PTC = papillary thyroid carcinoma microscopic examination. Initially, one hematoxylin-eosin (HE) -stained section was cut from each block for light microscopy. If the lymph node was classified as negative, additional step sections at 200-μm interval were cut through the block. These were stained with HE, except for one section which was used for immunohistochemical detection of cytokeratins (CK) (dilution 1 : 100, clone AE1/AE3, Dako (Glostrup, Denmark)).
The pathologic reporting of lymph nodes were as follows (3):
• negative -reactive changes, sinus histiocytosis, lymphostasis, benign inclusions etc.;
Results
Presence of tumor cells in the lymph nodes was found in 5/12 (42%) patients.
Micrometastases of SCC were found in two patients ( Fig. 1 and 2) . One patient had an isolated micrometastasis in one lymph node and the second patient had three micrometastases in two lymph nodes. Furthermore, ITC in one lymph node were found in two other patients. In the remaining one patient with oropharyngeal SCC, a micrometastasis of papillary thyroid carcinoma (PTC) was detected (Table 1) .
Positive lymph nodes were localized in level II in three patients with SCC of larynx, hypopharynx and tongue base, respectively, in level I in one patient with SCC of oral tongue and in level III in one patient with PTC. Micrometastases of SCC and ITC were found in patients with T2-T4 tumors (Table 1) . 
Discussion
In cases of diagnosed metastases in cervical lymph nodes one ought to differentiate macrometastases from occult metastases, micrometastases and ITC. Macrometastasis is a lymph node suspicious on clinical examination or radiological images. Occult or subclinical metastasis is not detectable by imaging methods or physical examination of the lymph node. Micrometastasis is tumor lymph node deposit larger than 0.2 mm but not exceeding 2.0 mm.
Tumor cell deposits smaller than 0.2 mm are classified as ITC (3, 4) . In addition, there is another criterion for diagnosis of ITC as a cluster not exceeding 200 tumor cells in one slide. Furthermore, ITC are divided into those detectable by light microscopy or into those detectable by immunohistochemistry or molecular methods only (4, 5) . Nowadays, there is no imaging technique which would have as close as 100% sensitivity or specificity in detecting lymph node metastases. Clinical examination including the newest imaging modalities give false negative results in about 20-30% cases (6) . Microscopic examination of dissected lymph nodes still remains the gold standard for detection of lymph node metastases. However, if a lymph node is examined only by one central section, micrometastases, which are typically localized in the subcapsular sinuses of lymph nodes, are likely missed (7) . For this reason, it is very difficult to diagnose micrometastases by routine histopathological examinations (6, 8) . Many authors state significantly increased detection rate of micrometastases by examining serial histological sections in combination with immunohistochemical or molecular procedures (5, 9-11). However, wider use of these methods in clinical practice is prevents their time consuming and higher cost.
Detection of micrometastases by immunohistochemistry has been a priority especially in the breast cancer. Dowlatshahi was one of the first authors to write about high occurrence of micrometastases not detected by standard histological examination (12) . After examination of sentinel lymph nodes of 52 patients with breast carcinoma by standard histological examination (2 mm thick sections), 6 patients had positive results. However, after further and more detailed (serial 0.25 mm thick sections) immunohistochemical examination, the number of positive results increased to 30/52 (58%) patients. Many authors in recent years have focused on detection of HNSCC micrometastases using immunohistochemical methods. Positive results in patients with clinical N0 stage varies widely from 2 to 58% (13) (14) (15) (16) (17) (18) , which indicates that the methods for detection are not united and the percentage of positive results depends on the experience of the pathologist. In our study, micrometastases or ITC were detected in 5 cases (42%), 4 patients (33%) had a metastases of SCC and 1 patient (9%) had an accidental finding of PTC micrometastasis.
At present, the prognostic significance of ITC remains unclear. On the other hand, the presence of micrometastases is clinically significant (8, (18) (19) (20) . Nieuwenhuis et al. found that the survival of patients with cN0 but with one or more micrometastases (detected by molecular analysis) was worse compared to patients without micrometastases (10) . Similar results were published by Xu et al. (18) (19) and Yamazaki et al. (21) . Presence of unrecognized micrometastases or ones left in situ can also explain regional tumor recurrence in patients with N0 stage or in patients with N+ stage after selective neck dissection. The assumption of micrometastases left in situ turning into clinically significant metastases makes us further indicating elective neck dissection or radiotherapy in HNSCC with higher metastatic potential.
Conclusions
• HNSSC has a significant potential for creating micrometastases which frequency is higher compared to clinically detected macrometastases. • Elective neck dissection or radiotherapy of the neck should be considered in patients with high risk of occult metastases or micrometastases.
